EFFICACY AND SAFETY OF ACETYLSALICYLIC ACID IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES

Acetylsalicylic acid (ASA) use in the primary and secondary prevention of cardiovascular diseases is focused. Mode of ASA disaggregation action is discussed. Data of randomized controlled trials on ASA efficacy and safety in primary and secondary prevention are presented. The main groups of patients...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: S. N. Tolpygina, S. Yu. Martsevich, E. N. Khoseva, N. V. Kiseleva
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Столичная издательская компания 2015-12-01
Cyfres:Рациональная фармакотерапия в кардиологии
Pynciau:
disaggregation therapy
acetylsalicylic acid
enteric-soluble form
primary and secondary prevention
risk of cardiovascular complications
platelet aggregation
therapy safety
Mynediad Ar-lein:https://www.rpcardio.online/jour/article/view/560
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg